Exane Derivatives’s SilverCrest Metals Inc. Common Shares SILV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.74K Sell
284
-47,248
-99% -$358K ﹤0.01% 452
2022
Q1
$423K Sell
47,532
-6,563
-12% -$55.4K 0.12% 210
2021
Q4
$428K Buy
54,095
+52,976
+4,734% +$430K 0.1% 199
2021
Q3
$7.81K Hold
1,119
﹤0.01% 715
2021
Q2
$9.1K Hold
1,119
﹤0.01% 748
2021
Q1
$9.04K Sell
1,119
-1,062
-49% -$9.73K ﹤0.01% 600
2020
Q4
$24.4K Hold
2,181
0.01% 504
2020
Q3
$18.5K Sell
2,181
-1,539
-41% -$14.6K 0.01% 444
2020
Q2
$34.1K Sell
3,720
-1,671
-31% -$12.6K 0.01% 377
2020
Q1
$28.1K Buy
5,391
+5,140
+2,048% +$32.5K 0.01% 394
2019
Q4
$1.68K Buy
+251
New +$1.48K ﹤0.01% 514

Other funds holding SILV

Exane Derivatives's SILV Position: Q2 2022 in Review

Exane Derivatives reduced its SilverCrest Metals Inc. Common Shares (SILV) stake by 99% in Q2 2022, selling an estimated $358K and leaving 284 shares worth $1.74K. The position accounts for ﹤0.01% of the portfolio, ranked #452.

Exane Derivatives first reported a position in SILV in Q4 2019 and has held it in 11 quarters since. The position peaked at $428K in Q4 2021. 141 funds tracked by Wall St. Rank hold SILV as of Q2 2022.

  • Exane Derivatives held 284 shares of SilverCrest Metals Inc. Common Shares worth $1.74K as of Q2 2022.
  • Exane Derivatives sold 47,248 SilverCrest Metals Inc. Common Shares shares in Q2 2022, an estimated $358K.
  • SilverCrest Metals Inc. Common Shares made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #452 holding.
  • Exane Derivatives first reported a position in SilverCrest Metals Inc. Common Shares in Q4 2019 and has held it in 11 quarters since.
  • Exane Derivatives's SilverCrest Metals Inc. Common Shares position peaked at $428K in Q4 2021.
  • 141 funds tracked by Wall St. Rank held SilverCrest Metals Inc. Common Shares as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.